Rothschild & CO Asset Management Us Inc. Novavax Inc Transaction History

Rothschild & CO Asset Management Us Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$36.28 - $75.29 $1.44 Million - $2.99 Million	-39,753 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $1.32 Million - $2.71 Million	-18,966 Reduced 32.3%	39,753 $2.93 Million
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $242,746 - $393,217	-1,804 Reduced 2.98%	58,719 $8.4 Million
Q3 2021 Nov 09, 2021	SELL	$177.8 - $270.58 $3.02 Million - $4.59 Million	-16,972 Reduced 21.9%	60,523 $12.5 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $1.75 Million - $3.73 Million	-14,460 Reduced 15.73%	77,495 $16.5 Million
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $10.4 Million - $29.4 Million	91,955 New	91,955 $16.7 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.